The content is available as a PDF (733.0 KB).
Contributor Information
Stanley Perlman, Email: Stanley-Perlman@uiowa.edu
Kathryn V. Holmes, Email: Kathryn.Holmes@ucHSC.edu
References
- 1.Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394. doi: 10.1126/science.1085952. [DOI] [PubMed] [Google Scholar]
- 2.Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 2004;279:3197. doi: 10.1074/jbc.C300520200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liu S, Xiao G, Chen Y, et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet. 2004;363:938. doi: 10.1016/S0140-6736(04)15788-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.He Y, Jiang S. Vaccine design for severe acute respiratory syndrome coronavirus. Viral Immunol. 2005;18:327. doi: 10.1089/vim.2005.18.327. [DOI] [PubMed] [Google Scholar]
- 5.Jiang S, He Y, Liu S. SARS vaccine development. Emerg. Infect. Dis. 2005;11:1016. doi: 10.3201/eid1107.050219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428:561. doi: 10.1038/nature02463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci, USA. 2004;101:6641. doi: 10.1073/pnas.0401939101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 2004;363:2122. doi: 10.1016/S0140-6736(04)16501-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nie Y, Wang G, Shi X, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 2004;190:1119. doi: 10.1086/423286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.He Y, Lu H, Siddiqui P, Zhou Y, Jiang S. Receptor-binding domain of SARS coronavirus spike protein contains multiple conformational-dependant epitopes that induce highly potent neutralizing antibodies. J. Immunol. 2004;174:4908. doi: 10.4049/jimmunol.174.8.4908. [DOI] [PubMed] [Google Scholar]
- 11.He Y, Zhou Y, Siddiqui P, Jiang S. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochem. Biophys. Res. Commun. 2004;325:445. doi: 10.1016/j.bbrc.2004.10.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J. Immunol. 2004;173:4050. doi: 10.4049/jimmunol.173.6.4050. [DOI] [PubMed] [Google Scholar]
- 13.He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 2004;324:773. doi: 10.1016/j.bbrc.2004.09.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology. 2005;334:74. doi: 10.1016/j.virol.2005.01.034. [DOI] [PMC free article] [PubMed] [Google Scholar]